| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |